Nanoparticle‐Mediated Blocking of Excessive Inflammation for Prevention of Heart Failure Following Myocardial Infarction
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanoparticle‐Mediated Blocking of Excessive Inflammation for Prevention of Heart Failure Following Myocardial Infarction
Authors
Keywords
-
Journal
Small
Volume 17, Issue 32, Pages 2101207
Publisher
Wiley
Online
2021-07-03
DOI
10.1002/smll.202101207
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Attenuation of Tumor Necrosis Factor-α Induced Inflammation by Umbilical Cord-Mesenchymal Stem Cell Derived Exosome-Mimetic Nanovesicles in Endothelial Cells
- (2020) Kyoung-Won Ko et al. Tissue Engineering and Regenerative Medicine
- Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis
- (2020) Phuong-Uyen C. Dinh et al. Nature Communications
- Engineered M13 Peptide Carrier Promotes Angiogenic Potential of Patient-Derived Human Cardiac Progenitor Cells and In Vivo Engraftment
- (2020) Woong Bi Jang et al. Tissue Engineering and Regenerative Medicine
- IL-2 enhances ex vivo–expanded regulatory T-cell persistence after adoptive transfer
- (2020) Scott N. Furlan et al. Blood Advances
- Trends in Recurrent Coronary Heart Disease Following Myocardial Infarction Among US Women and Men Between 2008 and 2017
- (2020) Sanne A.E. Peters et al. CIRCULATION
- Stem cell therapy: A novel approach for myocardial infarction
- (2019) Seyed Mostafa Parizadeh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Material design for lymph node drug delivery
- (2019) Alex Schudel et al. Nature Reviews Materials
- Fropofol Prevents Disease Progression in Mice with Hypertrophic Cardiomyopathy
- (2019) Yiyuan Huang et al. CARDIOVASCULAR RESEARCH
- Risk Factors and Trends in Incidence of Heart Failure Following Acute Myocardial Infarction
- (2018) Jennifer Wellings et al. AMERICAN JOURNAL OF CARDIOLOGY
- A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects
- (2018) Ellen Kraig et al. EXPERIMENTAL GERONTOLOGY
- Clinical Grade Regulatory CD4+ T Cells (Tregs): Moving Toward Cellular-Based Immunomodulatory Therapies
- (2018) Richard Duggleby et al. Frontiers in Immunology
- Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance
- (2018) Qunfang Zhang et al. Frontiers in Immunology
- Recent advances on liposomal nanoparticles: synthesis, characterization and biomedical applications
- (2017) Yunes Panahi et al. Artificial Cells Nanomedicine and Biotechnology
- Reprogramming the Local Lymph Node Microenvironment Promotes Tolerance that Is Systemic and Antigen Specific
- (2016) Lisa H. Tostanoski et al. Cell Reports
- Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality
- (2015) Gregory A. Roth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulatory T cells are recruited in the infarcted mouse myocardium and may modulate fibroblast phenotype and function
- (2014) Amit Saxena et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Foxp3 + CD4 + T Cells Improve Healing After Myocardial Infarction by Modulating Monocyte/Macrophage Differentiation
- (2014) Johannes Weirather et al. CIRCULATION RESEARCH
- Leukocyte Behavior in Atherosclerosis, Myocardial Infarction, and Heart Failure
- (2013) F. K. Swirski et al. SCIENCE
- Healing and adverse remodelling after acute myocardial infarction: role of the cellular immune response
- (2012) Anja M van der Laan et al. HEART
- Regulatory T Lymphocytes Attenuate Myocardial Infarction-Induced Ventricular Remodeling in Mice
- (2011) Kazuaki Matsumoto et al. International Heart Journal
- Declining In-Hospital Mortality and Increasing Heart Failure Incidence in Elderly Patients With First Myocardial Infarction
- (2009) Azam Torabi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Application of Electrostatic Dry Powder Deposition Technology to Coat Drug-Eluting Stents
- (2009) Ravi Kumar Nukala et al. PHARMACEUTICAL RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started